FDA.reportPublic FDA data

1.5 ML Leqvio 189 MG/ML Prefilled Syringe

RxCUI
2588269
RxNorm name
1.5 ML Leqvio 189 MG/ML Prefilled Syringe
Display name
1.5 ML Leqvio 189 MG/ML Prefilled Syringe
Full name
1.5 ML Leqvio 189 MG/ML Prefilled Syringe
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LEQVIOINCLISIRANNovartis Pharmaceuticals Corporation6fc0afca-4513-4c35-b594-6544aee29a442026-02-12Warnings, Adverse reactionsExact identifier
rxcui: 2588269

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
6fc0afca-4513-4c35-b594-6544aee29a441.5 ML Leqvio 189 MG/ML Prefilled SyringeSY12These highlights do not include all the information needed to use LEQVIO safely and effectively. See full prescribing information for LEQVIO. LEQVIO ® (inclisiran) injection, for subcutaneous use Initial U.S. Approval: 202120260212
6fc0afca-4513-4c35-b594-6544aee29a44Leqvio 284 MG (equivalent to 300 MG inclisiran sodium) per 1.5 ML Prefilled SyringeSY12These highlights do not include all the information needed to use LEQVIO safely and effectively. See full prescribing information for LEQVIO. LEQVIO ® (inclisiran) injection, for subcutaneous use Initial U.S. Approval: 202120260212
6fc0afca-4513-4c35-b594-6544aee29a44LEQVIO 284 MG in 1.5 ML Prefilled SyringePSN12These highlights do not include all the information needed to use LEQVIO safely and effectively. See full prescribing information for LEQVIO. LEQVIO ® (inclisiran) injection, for subcutaneous use Initial U.S. Approval: 202120260212
6fc0afca-4513-4c35-b594-6544aee29a441.5 ML inclisiran 189 MG/ML Prefilled Syringe [Leqvio]SBD12These highlights do not include all the information needed to use LEQVIO safely and effectively. See full prescribing information for LEQVIO. LEQVIO ® (inclisiran) injection, for subcutaneous use Initial U.S. Approval: 202120260212